Homo sapiens (human): 595
Help
Entry
595 CDS
T01001
Symbol
CCND1, BCL1, D11S287E, PRAD1, U21B31
Name
(RefSeq) cyclin D1
KO
K04503
G1/S-specific cyclin-D1
Organism
hsa
Homo sapiens (human)
Pathway
hsa01522
Endocrine resistance
hsa04068
FoxO signaling pathway
hsa04110
Cell cycle
hsa04115
p53 signaling pathway
hsa04151
PI3K-Akt signaling pathway
hsa04152
AMPK signaling pathway
hsa04218
Cellular senescence
hsa04310
Wnt signaling pathway
hsa04340
Hedgehog signaling pathway
hsa04371
Apelin signaling pathway
hsa04390
Hippo signaling pathway
hsa04510
Focal adhesion
hsa04530
Tight junction
hsa04630
JAK-STAT signaling pathway
hsa04917
Prolactin signaling pathway
hsa04919
Thyroid hormone signaling pathway
hsa04921
Oxytocin signaling pathway
hsa04933
AGE-RAGE signaling pathway in diabetic complications
hsa04934
Cushing syndrome
hsa04936
Alcoholic liver disease
hsa05160
Hepatitis C
hsa05162
Measles
hsa05163
Human cytomegalovirus infection
hsa05165
Human papillomavirus infection
hsa05166
Human T-cell leukemia virus 1 infection
hsa05167
Kaposi sarcoma-associated herpesvirus infection
hsa05169
Epstein-Barr virus infection
hsa05200
Pathways in cancer
hsa05203
Viral carcinogenesis
hsa05205
Proteoglycans in cancer
hsa05206
MicroRNAs in cancer
hsa05207
Chemical carcinogenesis - receptor activation
hsa05210
Colorectal cancer
hsa05212
Pancreatic cancer
hsa05213
Endometrial cancer
hsa05214
Glioma
hsa05215
Prostate cancer
hsa05216
Thyroid cancer
hsa05218
Melanoma
hsa05219
Bladder cancer
hsa05220
Chronic myeloid leukemia
hsa05221
Acute myeloid leukemia
hsa05222
Small cell lung cancer
hsa05223
Non-small cell lung cancer
hsa05224
Breast cancer
hsa05225
Hepatocellular carcinoma
hsa05226
Gastric cancer
hsa05416
Viral myocarditis
Network
nt06160
Human T-cell leukemia virus 1 (HTLV-1)
nt06162
Hepatitis B virus (HBV)
nt06163
Hepatitis C virus (HCV)
nt06164
Kaposi sarcoma-associated herpesvirus (KSHV)
nt06165
Epstein-Barr virus (EBV)
nt06166
Human papillomavirus (HPV)
nt06167
Human cytomegalovirus (HCMV)
nt06170
Influenza A virus (IAV)
nt06181
Salmonella
nt06210
ERK signaling (cancer)
nt06215
WNT signaling (cancer)
nt06219
JAK-STAT signaling (cancer)
nt06220
Calcium signaling (cancer)
nt06227
Nuclear receptor signaling (cancer)
nt06230
Cell cycle (cancer)
nt06260
Colorectal cancer
nt06261
Gastric cancer
nt06262
Pancreatic cancer
nt06263
Hepatocellular carcinoma
nt06264
Renal cell carcinoma
nt06265
Bladder cancer
nt06266
Non-small cell lung cancer
nt06267
Small cell lung cancer
nt06268
Melanoma
nt06270
Breast cancer
nt06271
Endometrial cancer
nt06273
Glioma
nt06274
Thyroid cancer
nt06275
Acute myeloid leukemia
nt06276
Chronic myeloid leukemia
nt06505
WNT signaling
Element
N00001
EGF-EGFR-RAS-ERK signaling pathway
N00005
Mutation-activated MET to RAS-ERK signaling pathway
N00007
EML4-ALK fusion kinase to RAS-ERK signaling pathway
N00012
Mutation-activated KRAS/NRAS to ERK signaling pathway
N00014
Mutation-activated EGFR to RAS-ERK signaling pathway
N00023
EGF-EGFR-PLCG-ERK signaling pathway
N00024
Mutation-activated EGFR to PLCG-ERK signaling pathway
N00025
EML4-ALK fusion kinase to PLCG-ERK signaling pathway
N00056
Wnt signaling pathway
N00057
Mutation-inactivated APC to Wnt signaling pathway
N00058
Mutation-activated CTNNB1 to Wnt signaling pathway
N00059
FZD7-overexpression to Wnt signaling pathway
N00060
LRP6-overexpression to Wnt signaling pathway
N00061
CDH1-reduced expression to beta-catenin signaling pathway
N00066
MDM2-p21-Cell cycle G1/S
N00067
Deleted p14(ARF) to p21-cell cycle G1/S
N00068
Amplified MDM2 to p21-cell cycle G1/S
N00069
p16-Cell cycle G1/S
N00070
Mutation-inactivated p16(INK4a) to p16-cell cycle G1/S
N00071
Deleted p16(INK4a) to p16-cell cycle G1/S
N00072
Amplified CDK4 to cell cycle G1/S
N00073
Mutation-activated CDK4 to cell cycle G1/S
N00076
Mutation-inactivated p14(ARF) to p21-cell cycle G1/S
N00088
Amplified MYC to p15-cell cycle G1/S
N00089
Amplified MYC to cell cycle G1/S
N00090
p15-Cell cycle G1/S
N00175
KSHV LANA to Wnt signaling pathway
N00242
Mutation-inactivated AXIN to Wnt signaling pathway
N00257
Loss of CDH1 to beta-catenin signaling pathway
N00258
Mutation-inactivated CDH1 to beta-catenin signaling pathway
N00275
Amplified CCND1 to cell cycle G1/S
N00287
ESR1-positive to nuclear-initiated estrogen signaling pathway
N00347
p300-p21-Cell cycle G1/S
N00483
EBV EBNA3C to cell cycle G1/S
N00510
HTLV-1 Tax to CREB-mediated transcription
N00513
Mutation-activated EGFR to RAS-ERK signaling pathway
N00529
HCV core to RXRA/PPARA-mediated transcription
N00530
HCV core to RXRA/LXRA-mediated transcription
N01342
Nicotine to Jak-STAT signaling pathway
N01360
P4-PR-RAS-ERK signaling pathway
N01361
P4/MPA to PR-RAS-ERK signaling pathway
N01362
Nuclear-initiated progesterone signaling pathway
Disease
H00006
Hairy cell leukemia
H00010
Multiple myeloma
H00016
Oral cancer
H00017
Esophageal cancer
H00020
Colorectal cancer
H00031
Breast cancer
H00055
Laryngeal cancer
H00559
von Hippel-Lindau syndrome
H01464
Mantle cell lymphoma
Drug target
Omacetaxine mepesuccinate:
D08956
Brite
KEGG Orthology (KO) [BR:
hsa00001
]
09130 Environmental Information Processing
09132 Signal transduction
04310 Wnt signaling pathway
595 (CCND1)
04340 Hedgehog signaling pathway
595 (CCND1)
04390 Hippo signaling pathway
595 (CCND1)
04371 Apelin signaling pathway
595 (CCND1)
04630 JAK-STAT signaling pathway
595 (CCND1)
04068 FoxO signaling pathway
595 (CCND1)
04151 PI3K-Akt signaling pathway
595 (CCND1)
04152 AMPK signaling pathway
595 (CCND1)
09140 Cellular Processes
09143 Cell growth and death
04110 Cell cycle
595 (CCND1)
04115 p53 signaling pathway
595 (CCND1)
04218 Cellular senescence
595 (CCND1)
09144 Cellular community - eukaryotes
04510 Focal adhesion
595 (CCND1)
04530 Tight junction
595 (CCND1)
09150 Organismal Systems
09152 Endocrine system
04917 Prolactin signaling pathway
595 (CCND1)
04921 Oxytocin signaling pathway
595 (CCND1)
04919 Thyroid hormone signaling pathway
595 (CCND1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
595 (CCND1)
05206 MicroRNAs in cancer
595 (CCND1)
05205 Proteoglycans in cancer
595 (CCND1)
05207 Chemical carcinogenesis - receptor activation
595 (CCND1)
05203 Viral carcinogenesis
595 (CCND1)
09162 Cancer: specific types
05210 Colorectal cancer
595 (CCND1)
05212 Pancreatic cancer
595 (CCND1)
05225 Hepatocellular carcinoma
595 (CCND1)
05226 Gastric cancer
595 (CCND1)
05214 Glioma
595 (CCND1)
05216 Thyroid cancer
595 (CCND1)
05221 Acute myeloid leukemia
595 (CCND1)
05220 Chronic myeloid leukemia
595 (CCND1)
05218 Melanoma
595 (CCND1)
05219 Bladder cancer
595 (CCND1)
05215 Prostate cancer
595 (CCND1)
05213 Endometrial cancer
595 (CCND1)
05224 Breast cancer
595 (CCND1)
05222 Small cell lung cancer
595 (CCND1)
05223 Non-small cell lung cancer
595 (CCND1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
595 (CCND1)
05160 Hepatitis C
595 (CCND1)
05162 Measles
595 (CCND1)
05163 Human cytomegalovirus infection
595 (CCND1)
05167 Kaposi sarcoma-associated herpesvirus infection
595 (CCND1)
05169 Epstein-Barr virus infection
595 (CCND1)
05165 Human papillomavirus infection
595 (CCND1)
09166 Cardiovascular disease
05416 Viral myocarditis
595 (CCND1)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
595 (CCND1)
04933 AGE-RAGE signaling pathway in diabetic complications
595 (CCND1)
04934 Cushing syndrome
595 (CCND1)
09176 Drug resistance: antineoplastic
01522 Endocrine resistance
595 (CCND1)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Cyclin_N
Cyclin_C
Motif
Other DBs
NCBI-GeneID:
595
NCBI-ProteinID:
NP_444284
OMIM:
168461
HGNC:
1582
Ensembl:
ENSG00000110092
Pharos:
P24385
(Tchem)
UniProt:
P24385
Q6FI00
Structure
PDB
LinkDB
All DBs
Position
11:69641156..69654474
Genome browser
AA seq
295 aa
AA seq
DB search
MEHQLLCCEVETIRRAYPDANLLNDRVLRAMLKAEETCAPSVSYFKCVQKEVLPSMRKIV
ATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVASKMKETIPLT
AEKLCIYTDNSIRPEELLQMELLLVNKLKWNLAAMTPHDFIEHFLSKMPEAEENKQIIRK
HAQTFVALCATDVKFISNPPSMVAAGSVVAAVQGLNLRSPNNFLSYYRLTRFLSRVIKCD
PDCLRACQEQIEALLESSLRQAQQNMDPKAAEEEEEEEEEVDLACTPTDVRDVDI
NT seq
888 nt
NT seq
+upstream
nt +downstream
nt
atggaacaccagctcctgtgctgcgaagtggaaaccatccgccgcgcgtaccccgatgcc
aacctcctcaacgaccgggtgctgcgggccatgctgaaggcggaggagacctgcgcgccc
tcggtgtcctacttcaaatgtgtgcagaaggaggtcctgccgtccatgcggaagatcgtc
gccacctggatgctggaggtctgcgaggaacagaagtgcgaggaggaggtcttcccgctg
gccatgaactacctggaccgcttcctgtcgctggagcccgtgaaaaagagccgcctgcag
ctgctgggggccacttgcatgttcgtggcctctaagatgaaggagaccatccccctgacg
gccgagaagctgtgcatctacaccgacaactccatccggcccgaggagctgctgcaaatg
gagctgctcctggtgaacaagctcaagtggaacctggccgcaatgaccccgcacgatttc
attgaacacttcctctccaaaatgccagaggcggaggagaacaaacagatcatccgcaaa
cacgcgcagaccttcgttgccctctgtgccacagatgtgaagttcatttccaatccgccc
tccatggtggcagcggggagcgtggtggccgcagtgcaaggcctgaacctgaggagcccc
aacaacttcctgtcctactaccgcctcacacgcttcctctccagagtgatcaagtgtgac
ccggactgcctccgggcctgccaggagcagatcgaagccctgctggagtcaagcctgcgc
caggcccagcagaacatggaccccaaggccgccgaggaggaggaagaggaggaggaggag
gtggacctggcttgcacacccaccgacgtgcgggacgtggacatctga
Homo sapiens (human): 4609
Help
Entry
4609 CDS
T01001
Symbol
MYC, MRTL, MYCC, bHLHe39, c-Myc
Name
(RefSeq) MYC proto-oncogene, bHLH transcription factor
KO
K04377
Myc proto-oncogene protein
Organism
hsa
Homo sapiens (human)
Pathway
hsa04010
MAPK signaling pathway
hsa04012
ErbB signaling pathway
hsa04110
Cell cycle
hsa04151
PI3K-Akt signaling pathway
hsa04218
Cellular senescence
hsa04310
Wnt signaling pathway
hsa04350
TGF-beta signaling pathway
hsa04390
Hippo signaling pathway
hsa04550
Signaling pathways regulating pluripotency of stem cells
hsa04630
JAK-STAT signaling pathway
hsa04919
Thyroid hormone signaling pathway
hsa05132
Salmonella infection
hsa05160
Hepatitis C
hsa05161
Hepatitis B
hsa05163
Human cytomegalovirus infection
hsa05166
Human T-cell leukemia virus 1 infection
hsa05167
Kaposi sarcoma-associated herpesvirus infection
hsa05169
Epstein-Barr virus infection
hsa05200
Pathways in cancer
hsa05202
Transcriptional misregulation in cancer
hsa05205
Proteoglycans in cancer
hsa05206
MicroRNAs in cancer
hsa05207
Chemical carcinogenesis - receptor activation
hsa05210
Colorectal cancer
hsa05213
Endometrial cancer
hsa05216
Thyroid cancer
hsa05219
Bladder cancer
hsa05220
Chronic myeloid leukemia
hsa05221
Acute myeloid leukemia
hsa05222
Small cell lung cancer
hsa05224
Breast cancer
hsa05225
Hepatocellular carcinoma
hsa05226
Gastric cancer
hsa05230
Central carbon metabolism in cancer
Network
nt06160
Human T-cell leukemia virus 1 (HTLV-1)
nt06163
Hepatitis C virus (HCV)
nt06164
Kaposi sarcoma-associated herpesvirus (KSHV)
nt06165
Epstein-Barr virus (EBV)
nt06181
Salmonella
nt06210
ERK signaling (cancer)
nt06215
WNT signaling (cancer)
nt06227
Nuclear receptor signaling (cancer)
nt06230
Cell cycle (cancer)
nt06240
Transcription (cancer)
nt06260
Colorectal cancer
nt06261
Gastric cancer
nt06263
Hepatocellular carcinoma
nt06265
Bladder cancer
nt06267
Small cell lung cancer
nt06270
Breast cancer
nt06271
Endometrial cancer
nt06274
Thyroid cancer
nt06275
Acute myeloid leukemia
nt06505
WNT signaling
nt06526
MAPK signaling
Element
N00011
Mutation-activated FGFR3 to RAS-ERK signaling pathway
N00056
Wnt signaling pathway
N00057
Mutation-inactivated APC to Wnt signaling pathway
N00058
Mutation-activated CTNNB1 to Wnt signaling pathway
N00059
FZD7-overexpression to Wnt signaling pathway
N00060
LRP6-overexpression to Wnt signaling pathway
N00061
CDH1-reduced expression to beta-catenin signaling pathway
N00077
HRAS-overexpression to ERK signaling pathway
N00078
Mutation-activated HRAS to ERK signaling pathway
N00088
Amplified MYC to p15-cell cycle G1/S
N00089
Amplified MYC to cell cycle G1/S
N00090
p15-Cell cycle G1/S
N00092
Amplified MYC to p27-cell cycle G1/S
N00110
PLZF-RARA fusion to transcriptional activtion
N00133
EWSR1-FLI1 fusion to transcriptional activation
N00225
EBV EBNA2 to RBP-Jk-mediated transcription
N00242
Mutation-inactivated AXIN to Wnt signaling pathway
N00257
Loss of CDH1 to beta-catenin signaling pathway
N00258
Mutation-inactivated CDH1 to beta-catenin signaling pathway
N00287
ESR1-positive to nuclear-initiated estrogen signaling pathway
N00489
HTLV-1 p30II to c-myc-mediated transcription
N00512
HTLV-1 Tax to c-myc-mediated transcription
N00529
HCV core to RXRA/PPARA-mediated transcription
N00530
HCV core to RXRA/LXRA-mediated transcription
N01124
Salmonella AvrA to beta-catenin signaling pathway
N01344
NNK/NNN to RAS-ERK signaling pathway
N01602
ERK-MYC signaling pathway
Disease
H00001
B-cell acute lymphoblastic leukemia
H00002
T-cell acute lymphoblastic leukemia
H00008
Burkitt lymphoma
H00010
Multiple myeloma
H00013
Small cell lung cancer
H00016
Oral cancer
H00025
Penile cancer
H00027
Ovarian cancer
H00028
Choriocarcinoma
H00036
Osteosarcoma
H00041
Kaposi sarcoma
H00048
Hepatocellular carcinoma
H00055
Laryngeal cancer
H01463
Mycosis fungoides
H01509
Tonsillar cancer
H01554
Fallopian tube cancer
H01667
Medulloblastoma
H02434
Diffuse large B-cell lymphoma, not otherwise specified
Drug target
Omacetaxine mepesuccinate:
D08956
Brite
KEGG Orthology (KO) [BR:
hsa00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
4609 (MYC)
04012 ErbB signaling pathway
4609 (MYC)
04310 Wnt signaling pathway
4609 (MYC)
04350 TGF-beta signaling pathway
4609 (MYC)
04390 Hippo signaling pathway
4609 (MYC)
04630 JAK-STAT signaling pathway
4609 (MYC)
04151 PI3K-Akt signaling pathway
4609 (MYC)
09140 Cellular Processes
09143 Cell growth and death
04110 Cell cycle
4609 (MYC)
04218 Cellular senescence
4609 (MYC)
09144 Cellular community - eukaryotes
04550 Signaling pathways regulating pluripotency of stem cells
4609 (MYC)
09150 Organismal Systems
09152 Endocrine system
04919 Thyroid hormone signaling pathway
4609 (MYC)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
4609 (MYC)
05202 Transcriptional misregulation in cancer
4609 (MYC)
05206 MicroRNAs in cancer
4609 (MYC)
05205 Proteoglycans in cancer
4609 (MYC)
05207 Chemical carcinogenesis - receptor activation
4609 (MYC)
05230 Central carbon metabolism in cancer
4609 (MYC)
09162 Cancer: specific types
05210 Colorectal cancer
4609 (MYC)
05225 Hepatocellular carcinoma
4609 (MYC)
05226 Gastric cancer
4609 (MYC)
05216 Thyroid cancer
4609 (MYC)
05221 Acute myeloid leukemia
4609 (MYC)
05220 Chronic myeloid leukemia
4609 (MYC)
05219 Bladder cancer
4609 (MYC)
05213 Endometrial cancer
4609 (MYC)
05224 Breast cancer
4609 (MYC)
05222 Small cell lung cancer
4609 (MYC)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
4609 (MYC)
05161 Hepatitis B
4609 (MYC)
05160 Hepatitis C
4609 (MYC)
05163 Human cytomegalovirus infection
4609 (MYC)
05167 Kaposi sarcoma-associated herpesvirus infection
4609 (MYC)
05169 Epstein-Barr virus infection
4609 (MYC)
09171 Infectious disease: bacterial
05132 Salmonella infection
4609 (MYC)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors [BR:
hsa03000
]
4609 (MYC)
03019 Messenger RNA biogenesis [BR:
hsa03019
]
4609 (MYC)
Transcription factors [BR:
hsa03000
]
Eukaryotic type
Basic helix-loop-helix/leucine zipper (bHLH-ZIP)
Cell cycle controlling factors, Myc
4609 (MYC)
Messenger RNA biogenesis [BR:
hsa03019
]
Eukaryotic type
mRNA surveillance and transport factors
Factors involved in mRNA localization
Factors that have mRNA localization signals
4609 (MYC)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Myc_N
Myc-LZ
HLH
TRH
Motif
Other DBs
NCBI-GeneID:
4609
NCBI-ProteinID:
NP_002458
OMIM:
190080
HGNC:
7553
Ensembl:
ENSG00000136997
Pharos:
P01106
(Tbio)
UniProt:
P01106
Structure
PDB
LinkDB
All DBs
Position
8:127735434..127742951
Genome browser
AA seq
454 aa
AA seq
DB search
MDFFRVVENQQPPATMPLNVSFTNRNYDLDYDSVQPYFYCDEEENFYQQQQQSELQPPAP
SEDIWKKFELLPTPPLSPSRRSGLCSPSYVAVTPFSLRGDNDGGGGSFSTADQLEMVTEL
LGGDMVNQSFICDPDDETFIKNIIIQDCMWSGFSAAAKLVSEKLASYQAARKDSGSPNPA
RGHSVCSTSSLYLQDLSAAASECIDPSVVFPYPLNDSSSPKSCASQDSSAFSPSSDSLLS
STESSPQGSPEPLVLHEETPPTTSSDSEEEQEDEEEIDVVSVEKRQAPGKRSESGSPSAG
GHSKPPHSPLVLKRCHVSTHQHNYAAPPSTRKDYPAAKRVKLDSVRVLRQISNNRKCTSP
RSSDTEENVKRRTHNVLERQRRNELKRSFFALRDQIPELENNEKAPKVVILKKATAYILS
VQAEEQKLISEEDLLRKRREQLKHKLEQLRNSCA
NT seq
1365 nt
NT seq
+upstream
nt +downstream
nt
ctggatttttttcgggtagtggaaaaccagcagcctcccgcgacgatgcccctcaacgtt
agcttcaccaacaggaactatgacctcgactacgactcggtgcagccgtatttctactgc
gacgaggaggagaacttctaccagcagcagcagcagagcgagctgcagcccccggcgccc
agcgaggatatctggaagaaattcgagctgctgcccaccccgcccctgtcccctagccgc
cgctccgggctctgctcgccctcctacgttgcggtcacacccttctcccttcggggagac
aacgacggcggtggcgggagcttctccacggccgaccagctggagatggtgaccgagctg
ctgggaggagacatggtgaaccagagtttcatctgcgacccggacgacgagaccttcatc
aaaaacatcatcatccaggactgtatgtggagcggcttctcggccgccgccaagctcgtc
tcagagaagctggcctcctaccaggctgcgcgcaaagacagcggcagcccgaaccccgcc
cgcggccacagcgtctgctccacctccagcttgtacctgcaggatctgagcgccgccgcc
tcagagtgcatcgacccctcggtggtcttcccctaccctctcaacgacagcagctcgccc
aagtcctgcgcctcgcaagactccagcgccttctctccgtcctcggattctctgctctcc
tcgacggagtcctccccgcagggcagccccgagcccctggtgctccatgaggagacaccg
cccaccaccagcagcgactctgaggaggaacaagaagatgaggaagaaatcgatgttgtt
tctgtggaaaagaggcaggctcctggcaaaaggtcagagtctggatcaccttctgctgga
ggccacagcaaacctcctcacagcccactggtcctcaagaggtgccacgtctccacacat
cagcacaactacgcagcgcctccctccactcggaaggactatcctgctgccaagagggtc
aagttggacagtgtcagagtcctgagacagatcagcaacaaccgaaaatgcaccagcccc
aggtcctcggacaccgaggagaatgtcaagaggcgaacacacaacgtcttggagcgccag
aggaggaacgagctaaaacggagcttttttgccctgcgtgaccagatcccggagttggaa
aacaatgaaaaggcccccaaggtagttatccttaaaaaagccacagcatacatcctgtcc
gtccaagcagaggagcaaaagctcatttctgaagaggacttgttgcggaaacgacgagaa
cagttgaaacacaaacttgaacagctacggaactcttgtgcgtaa
DBGET
integrated database retrieval system